CLASS I Drug recall · Reported 22 Oct 2014 · FDA Enforcement Report

Lidocaine HCl Injection, USP, 2%, 20 mg per mL recalled by Hospira

Hospira is recalling Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free Single-Dose Vial, distributed nationwide in the US. The recall was initiated on 29 Jul 2014 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot Number: 25-550-DD, Exp: 1JAN2015
NDC0409-2066
Quantity recalled109,110 Vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0020-2015
FDA event ID
68901
Recalling firm
Hospira, Lake Forest, IL
Manufacturer
Hospira, Inc.
Classification
Class I
Status
Terminated
Recall initiated
29 Jul 2014
FDA classified
10 Oct 2014
Reported
22 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Particulate Matter
Drug class
Pain Medication

Timeline

29 Jul 2014Recall initiated by company
10 Oct 2014Classified by FDA+73 days
22 Oct 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.

Product as listed by the FDA

Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and Nerve Block including Epidural and Caudal, Manufactured by: Hospira, Inc., Lake Forest, IL, 60045, NDC 0409-2066-05

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.

Which lots are affected?

Lot Number: 25-550-DD, Exp: 1JAN2015

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hospira

All 225

Other Lidocaine recalls

All 119